NutriBand (NTRB) Finished Goods (2018)
NutriBand (NTRB) posted Finished Goods of $4133.0 for Q4 2018, little changed sequentially from $4133.0 in Q3 2018.
NutriBand (NTRB) Finished Goods (2018) Analysis & Trends
NutriBand has reported Finished Goods for 1 years, with the latest figure at $4133.0 in Q4 2018.
- Quarterly Finished Goods changed N/A year-over-year to $4133.0 in Q4 2018, while the trailing twelve-month figure through Oct 2018 was $4133.0 (changed N/A YoY) and the FY2018 annual result came in at $4133.0, changed N/A from the prior year.
- Finished Goods held at $4133.0 in Q4 2018 per NTRB's latest filing, from $4133.0 in the prior quarter.
- Over five years, Finished Goods peaked at $4133.0 in Q1 2018 and troughed at $4133.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2018 | 4,133.00 |
| Jul 31, 2018 | 4,133.00 |
| Jan 31, 2018 | 4,133.00 |